Generex Biotechnology
Miramar, US · Delaware corporation
Founders & leadership
AC
Anthony CrisciChief Legal Officer
JT
Jason TerrellChief Scientific Officer
TT
Terry ThompsonChief Operating Officer
AR
Andrew RoChief Investment Officer and Director
MC
Mark CorraoChief Financial Officer and Treasurer
RP
Richard PurcellExecutive Vice President of Research & Drug Development
JM
Joseph MoscatoCEO, President, and Chairman of the Board
MA
Mark A. FletcherExecutive
DB
David Brusegard, Ph.D.Executive
SF
Stephen FellowsExecutive
Board
BM
Brian McGeeIndependent Director
CE
Craig EagleIndependent Director
Reported raises · per SEC filings
Form D private placements$4M disclosed across 2 rounds · 2012–2020
▶$2MraisedSep 2020 · 3 investors · PharmaceuticalsRule 506(b)
▶$2MraisedSep 2020 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Brian McGeeDirector
- Craig EagleDirector
- Anthony CrisciExecutive Officer
- Jason TerrellExecutive Officer
- Mark PriolettiDirector
- Lawrence SalvoDirector
- Terry ThompsonExecutive Officer
- James AndersonDirector
- Andrew RoExecutive Officer, Director
- Mark CorraoExecutive Officer
- Richard PurcellExecutive Officer
- Joseph MoscatoExecutive Officer, Director
- Amount sold
- $2M
- Sales commissions
- $80K
- Placement agents
- Dawson James Securities, Inc
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedFeb 2012 · 7 investors · PharmaceuticalsRule 506(b)
▶$2MraisedFeb 2012 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Eric von Hofe, Ph.D.Director
- James H. Anderson, Jr., M.D.Director
- Brian T. McGeeDirector
- Mark A. FletcherExecutive Officer, Director
- John P. BarrattDirector
- Nola E. MastersonDirector
- David Brusegard, Ph.D.Executive Officer
- Stephen FellowsExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $50K
- Finders' fees
- $160K
- Placement agents
- Seahawk Capital Partners, Inc.
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Generex Biotechnology raised?
- Generex Biotechnology has disclosed $4M raised across 2 rounds.
- Where is Generex Biotechnology headquartered?
- Generex Biotechnology is headquartered in Miramar, US.